Ghaidar, Donya
Sippel, Anna
Riemann-Lorenz, Karin
Kofahl, Christopher
Morrison, Rebecca
Kleiter, Ingo
Schmidt, Stephan
Dettmers, Christian
Schulz, Holger
Heesen, Christoph
Funding for this research was provided by:
Roche Pharma AG
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 9 November 2021
Accepted: 27 May 2022
First Online: 11 June 2022
Declarations
:
: Ethical approval has been obtained from the ethical committee of the Hamburg Chamber of Physicians (approval number: PV5770). Written informed consent was obtained from all participants, and all procedures were performed in accordance with the Helsinki Declaration.
: Not applicable, since the manuscript does not contain any person’s data.
: AS and CH are developers of the website. AS has received funding from Roche Pharma and salaries for talks from Novartis. CH has received research grants, congress travel compensations and salaries for talks from Biogen, Genzyme, Sanofi-Aventis, Bayer Healthcare, Merck, Teva Pharma, Roche Pharma, and Novartis. IK has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with with Alexion, Biogen, Celgene, Hexal, Horizon, Merck and Roche/Chugai. SSch has received fees for consulting and reimbursement for lecturing as well as attending symposia from Bayer Vital, Biogen, Merck, Roche, Genzyme and Teva. He has also received research funding from Bayer Vital and Merck. CD received honorarium from Biogen, Novartis and Roche for presentations. DG, RM, KRL, HS and CK declare that they have no competing interests.